Status:
UNKNOWN
A Combinatorial Biomarker for Infection Diagnosis in Children
Lead Sponsor:
Universität des Saarlandes
Conditions:
Respiratory Tract Infections
Fever
Eligibility:
All Genders
5+ years
Brief Summary
To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to ...
Eligibility Criteria
Inclusion
- Suspicion of acute bacterial or viral infection
- Requirement of at least one BV test during medical presentation
Exclusion
- lack of informed consent
Key Trial Info
Start Date :
February 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
770 Patients enrolled
Trial Details
Trial ID
NCT05971901
Start Date
February 24 2023
End Date
November 1 2024
Last Update
August 2 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Sana Kliniken
Berlin, Germany
2
Universitätsklinikum Bonn
Bonn, Germany
3
Saarland University
Homburg, Germany, 66421
4
Universitätsklinikum Würzburg
Würzburg, Germany